Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Change in Receivables (2016 - 2025)

Skinvisible's Change in Receivables history spans 14 years, with the latest figure at $4530.0 for Q1 2025.

  • On a quarterly basis, Change in Receivables changed N/A to $4530.0 in Q1 2025 year-over-year; TTM through Mar 2025 was -$9543.0, a N/A change, with the full-year FY2022 number at -$18991.0, down 348.7% from a year prior.
  • Change in Receivables hit $4530.0 in Q1 2025 for Skinvisible, up from -$14073.0 in the prior quarter.
  • Over the last five years, Change in Receivables for SKVI hit a ceiling of $4966.0 in Q4 2021 and a floor of -$14073.0 in Q4 2022.
  • Historically, Change in Receivables has averaged -$853.12 across 3 years, with a median of $726.0 in 2021.
  • Biggest five-year swings in Change in Receivables: skyrocketed 106.03% in 2021 and later tumbled 506.16% in 2022.
  • Tracing SKVI's Change in Receivables over 3 years: stood at $4966.0 in 2021, then tumbled by 383.39% to -$14073.0 in 2022, then surged by 132.19% to $4530.0 in 2025.
  • Business Quant data shows Change in Receivables for SKVI at $4530.0 in Q1 2025, -$14073.0 in Q4 2022, and $29.0 in Q2 2022.